BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23008939)

  • 1. Treatment of female pattern hair loss.
    Hassani M; Gorouhi F; Babakoohi S; Moghadam-Kia S; Firooz A
    Skinmed; 2012; 10(4):218-27. PubMed ID: 23008939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of female pattern hair loss with oral antiandrogens.
    Sinclair R; Wewerinke M; Jolley D
    Br J Dermatol; 2005 Mar; 152(3):466-73. PubMed ID: 15787815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
    Carmina E; Azziz R; Bergfeld W; Escobar-Morreale HF; Futterweit W; Huddleston H; Lobo R; Olsen E
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2875-2891. PubMed ID: 30785992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
    Nobari NN; Roohaninasab M; Sadeghzadeh-Bazargan A; Goodarzi A; Behrangi E; Nikkhah F; Ghassemi M
    Adv Clin Exp Med; 2023 Jul; 32(7):813-823. PubMed ID: 36897103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
    Vexiau P; Chaspoux C; Boudou P; Fiet J; Jouanique C; Hardy N; Reygagne P
    Br J Dermatol; 2002 Jun; 146(6):992-9. PubMed ID: 12072067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
    Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
    Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female pattern hair loss.
    Singal A; Sonthalia S; Verma P
    Indian J Dermatol Venereol Leprol; 2013; 79(5):626-40. PubMed ID: 23974580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss.
    Paradisi R; Porcu E; Fabbri R; Seracchioli R; Battaglia C; Venturoli S
    Ann Pharmacother; 2011 Apr; 45(4):469-75. PubMed ID: 21487083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyperandrogenic alopecia in women.
    Carmina E; Lobo RA
    Fertil Steril; 2003 Jan; 79(1):91-5. PubMed ID: 12524069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
    McCoy J; Goren A; Kovacevic M; Shapiro J
    J Biol Regul Homeost Agents; 2016; 30(4):1153-1155. PubMed ID: 28078868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss.
    Won YY; Lew BL; Sim WY
    Dermatol Ther; 2018 Mar; 31(2):e12588. PubMed ID: 29464847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of female pattern hair loss with the androgen receptor antagonist flutamide.
    Yazdabadi A; Sinclair R
    Australas J Dermatol; 2011 May; 52(2):132-4. PubMed ID: 21605098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5% Minoxidil: treatment for female pattern hair loss.
    Gupta AK; Foley KA
    Skin Therapy Lett; 2014; 19(6):5-7. PubMed ID: 25807073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
    Fabbrocini G; Cantelli M; Masarà A; Annunziata MC; Marasca C; Cacciapuoti S
    Int J Womens Dermatol; 2018 Dec; 4(4):203-211. PubMed ID: 30627618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female pattern hair loss.
    Ioannides D; Lazaridou E
    Curr Probl Dermatol; 2015; 47():45-54. PubMed ID: 26370643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know.
    Carvalho RM; Santos LDN; Ramos PM; Machado CJ; Acioly P; Frattini SC; Barcaui CB; Donda ALV; Melo DF
    J Cosmet Dermatol; 2022 Oct; 21(10):4171-4175. PubMed ID: 35032336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.